- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 405/06 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Patent holdings for IPC class C07D 405/06
Total number of patents in this class: 2350
10-year publication summary
|
207
|
176
|
180
|
174
|
230
|
176
|
137
|
121
|
127
|
28
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 19740 |
43 |
| Takeda Pharmaceutical Company Limited | 2961 |
42 |
| Janssen Pharmaceutica N.V. | 3839 |
36 |
| VALO Health, Inc. | 147 |
34 |
| Merck Sharp & Dohme LLC | 3689 |
29 |
| F. Hoffmann-La Roche AG | 7958 |
28 |
| AstraZeneca AB | 3042 |
28 |
| Eisai R&D Management Co., Ltd. | 1304 |
27 |
| Bristol-myers Squibb Company | 5080 |
25 |
| Allergan, Inc. | 2600 |
24 |
| Shionogi & Co., Ltd. | 914 |
22 |
| Pulmocide Limited | 39 |
22 |
| Boehringer Ingelheim International GmbH | 4629 |
20 |
| Merck Patent GmbH | 5909 |
19 |
| Astellas Pharma Inc. | 1145 |
18 |
| Bausch + Lomb Ireland Limited | 601 |
18 |
| Orion Corporation | 554 |
17 |
| Glaxosmithkline Intellectual Property Development Limited | 723 |
15 |
| Temple University of the Commonwealth System of Higher Education | 583 |
15 |
| Sumitomo Pharma Co., Ltd. | 626 |
14 |
| Other owners | 1854 |